Australia’s national medicines regulator, the Therapeutic Goods Administration (TGA), launches a crackdown on unregulated peptides after a surge in online use. Multiple outlets report that peptides marketed for performance enhancement or anti-ageing have gained popularity through social media, but many products are not regulated for safety, quality or effectiveness. The TGA says increased illegal imports are a key concern and warns the products pose a risk to consumers. The crackdown is described as a targeted enforcement action aimed at stopping the supply of illegal or unapproved peptide products in the country. While the coverage aligns on the regulator’s focus and rationale, specific enforcement measures and timelines are not detailed in the provided summaries. Overall, the reports present the action as a response to a growing market for non-approved peptides and an attempt to reduce potential harm to consumers who may purchase such products without appropriate medical oversight or quality controls.